Jamieson Wellness, Inc. (JWEL.TO)
45.68
+0.05
(+0.11%)
CAD |
TSX |
Aug 25, 16:00
Jamieson Wellness Total Assets (Quarterly) : 1.234B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.234B |
| March 31, 2026 | 1.200B |
| December 31, 2025 | 1.215B |
| September 30, 2025 | 1.214B |
| June 30, 2025 | 1.170B |
| March 31, 2025 | 1.131B |
| December 31, 2024 | 1.209B |
| September 30, 2024 | 1.135B |
| June 30, 2024 | 1.130B |
| March 31, 2024 | 1.132B |
| December 31, 2023 | 1.144B |
| September 30, 2023 | 1.138B |
| June 30, 2023 | 1.177B |
| March 31, 2023 | 1.079B |
| December 31, 2022 | 1.107B |
| September 30, 2022 | 1.096B |
| June 30, 2022 | 669.26M |
| March 31, 2022 | 653.29M |
| December 31, 2021 | 652.48M |
| September 30, 2021 | 665.24M |
| Date | Value |
|---|---|
| June 30, 2021 | 644.83M |
| March 31, 2021 | 633.81M |
| December 31, 2020 | 609.34M |
| September 30, 2020 | 607.82M |
| June 30, 2020 | 581.86M |
| March 31, 2020 | 579.46M |
| December 31, 2019 | 561.78M |
| September 30, 2019 | 580.79M |
| June 30, 2019 | 555.16M |
| March 31, 2019 | 545.97M |
| December 31, 2018 | 549.02M |
| September 30, 2018 | 534.53M |
| June 30, 2018 | 519.66M |
| March 31, 2018 | 508.49M |
| December 31, 2017 | 512.56M |
| September 30, 2017 | 521.26M |
| June 30, 2017 | 505.14M |
| March 31, 2017 | 504.68M |
| December 31, 2016 | 405.18M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Leef Brands, Inc. | 74.36M |
| NeutriSci International, Inc. | -- |
| Vitality Products, Inc. | 0.7236M |
| Genix Pharmaceuticals Corp. | 0.0334M |
| LSL Pharma Group, Inc. | 87.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 677.34M |
| Shareholders Equity (Quarterly) | 509.52M |
| Debt to Equity Ratio | 0.9369 |
| Current Ratio | 3.408 |
| Net Debt Paydown Yield | -0.46% |